$0.22
▲ +0.7% Today
as of Aug 5, 16:47 ET
Last 30 days
Recent Press Releases & News
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
COSM Marking Huge Growth and Buying Back Shares
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
Overview
52-week range
$0.24
$1.32
0% of range
Avg surprise (last 1)
-100.0%
Avg reaction (last 2)
-5.2%
0% positive
Latest IV / EM
2652%
EM ±616.7% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 21, 2026 | Mar/2026 | $-0.02 | $-0.01 | -100.0% | -300.0% | -10.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.17 | — | — | — | — | financials |
| Mon Aug 18, 2025 | Jun/2025 | $-0.06 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $0.01 | — | — | — | -0.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.45 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.15 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.11 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.27 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.09 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 17, 2026 | Jun/2026 | OTHER | $0.01 | -$0.06 | +116.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18M | — | $17M | $15M | $14M | — | $12M | $13M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $1M | — | $3M | $1M | $2M | — | $1M | $767,248 |
| Operating income | $-2M | — | $-2M | $-3M | $-833,145 | — | $-2M | $-3M |
| Net income | $-3M | — | $-5M | $-3M | $-818,097 | — | $-8M | $-3M |
| EPS (diluted) | $-0.06 | — | $-0.17 | $-0.10 | $-0.03 | — | $-0.45 | $-0.15 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $514,702 | $715,674 | $889,441 | — | — | $315,105 | — | — |
| Inventory | $6M | $6M | $6M | $5M | $5M | $4M | $5M | $4M |
| Total current assets | $37M | $38M | $38M | $31M | $28M | $25M | $36M | $33M |
| Total assets | $62M | $65M | $69M | $62M | $57M | $54M | $65M | $61M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $43M | $47M | $46M | $36M | $31M | $30M | $30M | $29M |
| Total equity | $20M | $18M | $23M | $26M | $26M | $25M | $35M | $32M |